{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-023264","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.382603+00:00","generated_at":"2026-06-14T19:55:58.957267+00:00","sec_items":["1.01","3.02","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Celularity raises $3.75M in PIPE; COO Glover resigns effective May 31","bullets":["Raised ~$3.75M via private placement of 5.8M shares at $0.52/share and warrants at $0.125/warrant.","COO Bradley Glover resigned effective May 31, 2023; departure not due to disagreement.","Warrants for up to 5.8M shares at $1.00, expiring May 18, 2028; proceeds for working capital.","Registration rights agreement filed to register resale of shares and warrant shares."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-023264","json":"https://secwatch.observer/filing/0000950170-23-023264.json","markdown":"https://secwatch.observer/filing/0000950170-23-023264.md","text":"https://secwatch.observer/filing/0000950170-23-023264.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023023264/0000950170-23-023264-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023023264/celu-20230516.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T19:55:58.957267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8525cbd53c","claim":"Bradley Glover resigned as Executive Vice President and Chief Operating Officer at Celularity Inc.","evidence_excerpt":"Bradley Glover, Ph.D., Executive Vice President and Chief Operating Officer and principal operating officer of Celularity, notified Celularity of his decision to resign from his role effective as of May 31, 2023 to pursue another opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023023264/0000950170-23-023264-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President and Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"b01b99e8e29286a1f0cdb3ca07db91cd66563e73","claim":"Celularity Inc entered into Securities Purchase Agreement with several accredited investors valued at aggregate purchase price of approximately $3.75 million for 5,813,945 shares of Class A common stock (effective 2023-05-17).","evidence_excerpt":"On May 17, 2023, Celularity Inc., or Celularity, entered into a securities purchase agreement with several accredited investors, providing for the private placement of (i) 5,813,945 shares of its Class A common stock, par value $0.0001 per share, or the Class A common stock, and (ii) accompanying warrants to purchase up to 5,813,945 shares of Class A common stock, or the PIPE Warrants, for $0.52 per share and $0.125 per accompanying PIPE Warrant, for an aggregate purchase price of approximately $3.75 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023023264/0000950170-23-023264-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"several accredited investors"},{"label":"Value","value":"aggregate purchase price of approximately $3.75 million for 5,813,945 shares of Class A common stock"},{"label":"Effective","value":"2023-05-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}